Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ATAI | US
-0.01
-0.83%
Consumer Defensive
Education & Training Services
30/06/2024
17/10/2024
1.20
1.20
1.21
1.15
ATAI Life Sciences N.V. a clinical-stage biopharmaceutical company engages in acquiring incubating and developing various therapeutics to treat depression anxiety addiction and other mental health disorders. Its principal clinical programs include RL-007 a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; GRX-917 a deuterated etifoxine for anxiety disorders; VLS-01 a NN-Dimethyltryptamine for treatment resistant depression (TRD); DMX-1002 an oral formulation of ibogaine a cholinergic glutamatergic and monoaminergic receptor modulator that is a naturally occurring psychedelic product isolated from a West African shrub for the treatment of opioid use disorders (OUD); and EMP-01 an oral formulation of an MDMA derivative being developed for the treatment of post-traumatic stress disorder. The company's other clinical programs comprise PCN-101 a subcutaneous formulation of R-ketamine as a therapy for psychiatric indications initially focused on TRD; and KUR-101 a formulation of deuterated mitragynine for the treatment of OUD. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin Germany with offices in New York and London.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Weakness based on declining price with high volume
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
71.5%1 month
54.4%3 months
55.5%6 months
60.5%-
-
1.10
0.10
0.08
0.27
306.52
-
-104.67M
201.36M
201.36M
-
-9.42K
-96.80
58.70
-31.51
21.01
7.40
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.19
Range1M
0.28
Range3M
0.67
Rel. volume
1.12
Price X volume
730.91K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
QuantaSing Group Limited American Depositary Shares | QSG | Education & Training Services | 3.33 | 170.21M | -5.93% | 3.72 | 12.80% |
Chegg Inc | CHGG | Education & Training Services | 1.53 | 158.62M | -1.92% | n/a | 168.68% |
Sunlands Online Education Group | STG | Education & Training Services | 7.42 | 101.59M | 2.06% | 1.73 | 59.07% |
iHuman Inc. | IH | Education & Training Services | 1.8475 | 95.78M | -3.27% | n/a | 0.32% |
China Online Education Group | COE | Education & Training Services | 14.54 | 83.19M | 3.12% | n/a | -9.83% |
Bright Scholar Education Holdings Limited | BEDU | Education & Training Services | 2 | 59.45M | 0.00% | n/a | 0.00% |
Common Stock | AACG | Education & Training Services | 1 | 31.95M | -0.99% | n/a | 48.46% |
Four Seasons Education (Cayman) Inc | FEDU | Education & Training Services | 12.5 | 26.45M | 5.13% | 40.58 | 8.92% |
Jianzhi Education Technology Group Company Limited American Depositary Shares | JZ | Education & Training Services | 0.98 | 19.78M | -2.00% | n/a | -125.02% |
EDTK | EDTK | Education & Training Services | 0.998 | 15.90M | 2.89% | n/a | 61.63% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
MultiPlan Corporation | MPLN | Healthcare Plans | 12.11 | 195.49M | 9.59% | n/a | 753.03% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.35 | 89.85M | 0.07% | 14.47 | 7.10% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
Marpai Inc. Class A Common Stock | MRAI | Healthcare Plans | 0.5628 | 9.31M | 0.27% | n/a | -15.38% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Sears Holdings Corporation | SHLD | Department Stores | 38.82 | 0 | 0.21% | n/a | |
UnitedHealth Group Incorporated | UNH | Healthcare Plans | 566.03 | 0 | -0.93% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.27 | 7.60 | Cheaper |
Ent. to Revenue | 306.52 | 15.45 | Expensive |
PE Ratio | - | 33.99 | - |
Price to Book | 1.10 | 2.40 | Cheaper |
Dividend Yield | - | 2.94 | - |
Std. Deviation (3M) | 55.49 | 63.97 | Par |
Debt to Equity | 0.10 | 0.31 | Cheaper |
Debt to Assets | 0.08 | 0.17 | Cheaper |
Market Cap | 201.36M | 1.75B | Emerging |